Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 31

  • Quoted phrase not found.
1.

A "bone marrow score" for predicting hematological disease in immunocompetent patients with fevers of unknown origin.

Wang HY, Yang CF, Chiou TJ, Yang SH, Gau JP, Yu YB, Liu CY, Liu JH, Chen PM, Hsu HC, Fung CP, Tzeng CH, Hsiao LT.

Medicine (Baltimore). 2014 Dec;93(27):e243. doi: 10.1097/MD.0000000000000243.

2.

X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.

Åström M, Hahn-Strömberg V, Zetterberg E, Vedin I, Merup M, Palmblad J.

Am J Hematol. 2015 Mar;90(3):E44-8. doi: 10.1002/ajh.23907. Epub 2015 Jan 16.

3.

Disruption of hSWI/SNF complexes in T cells by WAS mutations distinguishes X-linked thrombocytopenia from Wiskott-Aldrich syndrome.

Sarkar K, Sadhukhan S, Han SS, Vyas YM.

Blood. 2014 Nov 27;124(23):3409-19. doi: 10.1182/blood-2014-07-587642. Epub 2014 Sep 24.

4.

Severe fever with thrombocytopenia syndrome in children: a case report.

Wang LY, Cui N, Lu QB, Wo Y, Wang HY, Liu W, Cao WC.

BMC Infect Dis. 2014 Jul 3;14:366. doi: 10.1186/1471-2334-14-366.

5.

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme.

Rosenfeld MR, Ye X, Supko JG, Desideri S, Grossman SA, Brem S, Mikkelson T, Wang D, Chang YC, Hu J, McAfee Q, Fisher J, Troxel AB, Piao S, Heitjan DF, Tan KS, Pontiggia L, O'Dwyer PJ, Davis LE, Amaravadi RK.

Autophagy. 2014 Aug;10(8):1359-68. doi: 10.4161/auto.28984. Epub 2014 May 20.

6.

Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.

Wong JT, Ling M, Patil S, Banerji A, Long A.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):40-5. doi: 10.1016/j.jaip.2013.08.011. Epub 2013 Nov 1.

PMID:
24565767
7.

Allogeneic bone marrow transplantation appears to ameliorate IgA nephropathy in a patient with X-linked thrombocytopenia.

Hoshino A, Shimizu M, Matsukura H, Sakaki-Nakatsubo H, Nomura K, Miyawaki T, Kanegane H.

J Clin Immunol. 2014 Jan;34(1):53-7. doi: 10.1007/s10875-013-9964-4. Epub 2013 Nov 12.

PMID:
24217816
8.

Behçet's disease and pregnancy.

Noel N, Wechsler B, Nizard J, Costedoat-Chalumeau N, Boutin du LT, Dommergues M, Vauthier-Brouzes D, Cacoub P, Saadoun D.

Arthritis Rheum. 2013 Sep;65(9):2450-6. doi: 10.1002/art.38052.

9.

X-linked thrombocytopenia in a female with a complex familial pattern of X-chromosome inactivation.

Daza-Cajigal V, Martínez-Pomar N, Garcia-Alonso A, Heine-Suñer D, Torres S, Vega AK, Molina IJ, Matamoros N.

Blood Cells Mol Dis. 2013 Aug;51(2):125-9. doi: 10.1016/j.bcmd.2013.04.004. Epub 2013 May 18.

PMID:
23689198
10.

A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Gould N, Sill MW, Mannel RS, Thaker PH, DiSilvestro PA, Waggoner SE, Yamada SD, Armstrong DK, Fracasso PM, Walker JL.

Gynecol Oncol. 2012 Dec;127(3):506-10. doi: 10.1016/j.ygyno.2012.08.037. Epub 2012 Aug 31.

11.

Genetics of familial forms of thrombocytopenia.

Balduini CL, Savoia A.

Hum Genet. 2012 Dec;131(12):1821-32. doi: 10.1007/s00439-012-1215-x. Epub 2012 Aug 11. Review.

PMID:
22886561
12.

A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Gould N, Sill MW, Mannel RS, Thaker PH, Disilvestro P, Waggoner S, Yamada SD, Armstrong DK, Wenzel L, Huang H, Fracasso PM, Walker JL.

Gynecol Oncol. 2012 Apr;125(1):54-8. doi: 10.1016/j.ygyno.2011.12.417. Epub 2011 Dec 11.

13.

Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods.

Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK.

Blood. 2010 Sep 23;116(12):2127-33. doi: 10.1182/blood-2010-03-276691. Epub 2010 Jun 8.

14.

Phase II trial of gemcitabine in combination with cisplatin in inoperable or advanced hepatocellular carcinoma.

Chia WK, Ong S, Toh HC, Hee SW, Choo SP, Poon DY, Tay MH, Tan CK, Koo WH, Foo KF.

Ann Acad Med Singapore. 2008 Jul;37(7):554-8.

15.

Hemoperitoneum as the first manifestation of acute leukemia.

Nishimoto F, Okuno K, Kuragaki C, Miyanishi K, Boku K, Yamamoto T.

Gynecol Obstet Invest. 2008;66(1):12-3. doi: 10.1159/000114249. Epub 2008 Jan 30.

PMID:
18230909
16.
17.

Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.

Hong YS, Lee J, Lee SC, Hwang IG, Choi SH, Heo JS, Park JO, Park YS, Lim HY, Kang WK.

Cancer Chemother Pharmacol. 2007 Aug;60(3):321-8. Epub 2006 Dec 2.

PMID:
17143602
18.

Acute renal failure in a man with a small farm.

Cestero-Rivera R, Ramírez-Rivera J, Jaume-Anselmi F, Guerrero-Dujarric O.

Bol Asoc Med P R. 2006 Apr-Jun;98(2):114-6.

PMID:
19606799
19.

Eleven years of experience with dialysis associated tuberculosis.

Malik GH, Al-Harbi AS, Al-Mohaya S, Al-Khawajah H, Kechrid M, Al Hassan AO, Balbaid K, Shetia MS.

Clin Nephrol. 2002 Nov;58(5):356-62.

PMID:
12425486
20.

Raltitrexed in the treatment of elderly patients with advanced colorectal cancer: an active and low toxicity regimen.

Feliu J, Mel JR, Camps C, Escudero P, Aparicio J, Menéndez D, García Girón C, Rodriguez MR, Sánchez JJ, González Barón M; Oncopaz Cooperative Group Associated Hospitals.

Eur J Cancer. 2002 Jun;38(9):1204-11.

PMID:
12044507
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk